Fig. 1 ORTEP drawing of bis-p-bromobenzoate 25.
Notes and references
1 For structures of ciguatoxins, see: M. Murata, A. M. Legrand, Y.
Ishibashi, M. Fukui and T. Yasumoto, J. Am. Chem. Soc., 1990, 112,
4380; M. Satake, M. Murata and T. Yasumoto, Tetrahedron Lett., 1993,
34, 1975; M. Satake, A. Morohashi, H. Oguri, T. Oishi, M. Hirama, N.
Harada and T. Yasumoto, J. Am. Chem. Soc., 1997, 119, 11325; M.
Satake, M. Fukui, A. M. Legrand, P. Cruchet and T. Yasumoto,
Tetrahedron Lett., 1998, 39, 1197.
2 T. Suzuki, O. Sato, M. Hirama, Y. Yamamoto, M. Murata, T. Yasumoto
and N. Harada, Tetrahedron Lett., 1991, 32, 4505; H. Oguri, S.
Hishiyama, T. Oishi and M.Hirama, Synlett, 1995, 1252; H. Oguri, S.
Hishiyama, O. Sato, T. Oishi, M. Hirama, M. Murata, T. Yasumoto and
N. Harada, Tetrahedron, 1997, 53, 3057; T. Oishi, M. Shoji, N.
Kumahara and M. Hirama, Chem. Lett., 1997, 845; T. Oishi, Y. Nagumo
and M. Hirama, Synlett, 1997, 980; H. Oguri, S. Sasaki, T. Oishi and M.
Hirama, Tetrahedron Lett., 1999, 40, 5405; H. Oguri, S. Tanaka, S.
Hishiyama, T. Oishi, M. Hirama, T. Tumuraya, Y. Tomioka and M.
Mizugaki, Synthesis, 1999, 1431; H. Oguri, S. Tanaka, T. Oishi and M.
Hirama, Tetrahedron Lett., 2000, 41, 975; K. Maeda, T. Oishi, H. Oguri
and M. Hirama, Chem. Commun., 1999, 1063. For recent synthetic
studies of other groups, see: M. Sasaki, H. Fuwa, M. Ishikawa and K.
Tachibana, Org. Lett., 1999, 1, 1075; M. Inoue, M. Sasaki and K.
Tachibana, J. Org. Chem., 1999, 64, 9416; K. Fujiwara, H. Tanaka and
A. Murai, Chem. Lett., 2000, 610; T.-Z. Liu and M. Isobe, Tetrahedron,
2000, 56, 5391.
Scheme 3 Reagents and conditions: i, LDA, acrolein, THF, 278 °C, 10
min, separation, 47%; ii, (PCy3)2Cl2RuNCHPh (10 mol%), CH2Cl2 (0.01
M), reflux, 24 h, 60%; iii, LAlH, THF, 0 °C to rt, 5 h, 98%; iv, TBDPSCl,
Et3N, DMAP, CH2Cl2, rt, 16 h, 88%; v, (COCl)2, DMSO, Et3N, CH2Cl2,
260 °C, 30 min, 79%; vi, Me2Cu(CN)Li2, Et2O, 278 °C, 30 min, 74%; vii,
TBAF, AcOH, THF, rt, 5 h, 95%; viii, NaBH(OAc)3, AcOH, CH3CN,
220 °C, 2 h, 97%; ix, BnBr, NaH, THF, DMF, 0 °C to rt, 20 h; x,
TsOH·H2O, MeOH, H2O, rt, 1 d, 68%; xi, I2, PPh3, imidazole, THF, 0 °C
to rt, 1 d, 87%; xii, NaCN, DMSO, 40 °C, 2 d, 78%; xiii, TESOTf,
2,6-lutidine, CH2Cl2, 230 to 220 °C, 15 min, quant.; xiv, DIBAL-H,
CH2Cl2, 270 to 260 °C, 1 h; xv, PhSSPh, Bu3P, benzene, rt, 12 h, 73% (2
steps); xvi, TBAF, THF, rt, 3 h, 95%; xvii, EDC·HCl, DMAP, CH2Cl2, rt,
12 h, 58%; xviii, Cp2Ti[P(OEt)3]2 (3 or 4 eq.), THF, reflux, 1 h, 4: 52–67%,
21, 22: ~ 10%.
3 M. Maruyama, K. Maeda, T. Oishi, H. Oguri and M. Hirama,
Heterocycles, 2001, 54, 93.
4 T. Oishi, Y. Nagumo, M. Shoji, J.-Y. Le Brazidec, H. Uehara and M.
Hirama, Chem. Commun., 1999, 2035.
5 T. Oishi, Y. Nagumo and M. Hirama, Chem. Commun., 1998, 1041.
6 Recent reviews on ring-closing metathesis reactions, see: S. K.
Armstrong, J. Chem. Soc., Perkin Trans. 1, 1998, 371; R. H. Grubbs and
S. Chang, Tetrahedron, 1998, 54, 4413.
7 S. H. Pine, R. Zahler, D. A. Evans and R. H. Grubbs, J. Am. Chem. Soc.,
1980, 102, 3270.
8 K. C. Nicolaou, M. H. D. Postema and C. F. Claiborne, J. Am. Chem.
Soc., 1996, 118, 1565.
9 R. R. Schrock, J. S. Murdzek, G. C. Bazan, J. Robbins, M. DiMare and
M. O’Regan, J. Am. Chem. Soc., 1990, 112, 3875.
10 J. S. Clark and J. G. Kettle, Tetrahedron Lett., 1997, 38, 123; J. S. Clark
and J. G. Kettle, Tetrahedron Lett., 1997, 38, 127; J. S. Clark and J. G.
Kettle, Tetrahedron, 1999, 55, 8231.
11 J. D. Rainier and S. P. Allwein, J. Org. Chem., 1998, 63, 5310; J. D.
Rainier, S. P. Allwein and J. M. Cox, Org. Lett., 2000, 2, 231.
12 Y. Horikawa, M. Watanabe, T. Fujiwara and T. Takeda, J. Am. Chem.
Soc., 1997, 119, 1127; M. A. Rahim, T. Fujiwara and T. Takeda,
Tetrahedron, 2000, 56, 763.
Scheme 4 Reagents and conditions: i, H2, Pd(OH)2/C, EtOAc, MeOH, rt,
1 d; ii, p-MeOC6H4CH(OMe)2, CSA, CH2Cl2, rt, 30 min, 89% (2 steps); iii,
BOMCl, iPr2NEt, (CH2Cl)2, 40 °C, 12 h, 88%; iv, DIBAL-H, CH2Cl2, 280
to 230 °C, 2 h, 85%; v, MsCl, Et3N, (CH2Cl)2, 0 °C, 40 min; vi, NaCN,
18-crown-6, DMF, 50 °C, 3 d, 98% (2 steps); vii, DIBAL-H, CH2Cl2, 280
to 270 °C, 30 min; viii, Ph3PNC(Me)CO2Et, toluene, rt, 3 h, 84% (2 steps);
ix, DIBAL-H, CH2Cl2, 270 °C, 20 min, 94%; x,
-(2)-DET, Ti(OiPr)4,
D
ButOOH, MS4A, CH2Cl2, 250 to 230 °C, 2 h, 80%; xi, SO3·Py, Et3N,
CH2Cl2, 0 °C to rt, 2 h; xii, Ph3P+CH3Br2, NaHMDS, THF, 0 °C, 20 min,
96% (2 steps); xiii, DDQ, H2O, CH2Cl2, rt, 2 h, 82%.
13 T. Oishi, M. Shoji, K. Maeda, N. Kumahara and M. Hirama, Synlett,
1996, 1165; T. Oishi, M. Maruyama, M. Shoji, K. Maeda, N. Kumahara,
S. Tanaka and M. Hirama, Tetrahedron, 1999, 55, 7471.
14 The glycolate 12 was prepared from D-2-deoxyribose in 3 steps by
The enol ether 4 was converted to the IJKLM-ring fragment
23 according to our previously reported procedure (Scheme 4).4
The stereochemistry of 23 was unambiguously determined by
X-ray crystallography of the corresponding bis-p-bromo-
benzoate 25 (Fig. 1).17 Furthermore, the H-ring moiety was
successfully constructed in 23 in a similar manner to our
previously established route18 in 32% overall yield utilizing
acid catalyzed vinylepoxide–alcohol cyclization methodol-
ogy.19
In short, a practical synthetic route to the HIJKLM ring
fragment 27 has been establised. Further studies directed
towards the total synthesis of ciguatoxin CTX3C (1) are
currently in progress in our laboratory.
standard procedures.
15 G. C. Fu, S. T. Nguyen and R. H. Grubbs, J. Am. Chem. Soc., 1993, 115,
9856; P. Schwab, R. H. Grubbs and J. W. Ziller, J. Am. Chem. Soc.,
1996, 118, 100.
16 D. A. Evans, K. T. Chapman and E. M. Carreira, J. Am. Chem. Soc.,
1988, 110, 3560.
17 Crystal data: C39H48O10Br2, M = 836.61, orthorhombic, space group
P212121, Dc = 1.440 g cm23, Z = 4, a = 5.5284(3), b = 25.006(2), c
= 27.913(2) Å, V = 3858.7(4) Å3, F(000) = 1728, m(Mo-Ka) = 21,63
suppdata/cc/b0/b009506k/ for crystallographic files in .cif format.
18 T. Oishi, K. Maeda and M. Hirama, Chem. Commun., 1997, 1289.
19 K. C. Nicolaou, C. V. C. Prasad, P. K. Somers and C.-K. Hwang, J. Am.
Chem. Soc., 1989, 111, 5330.
382
Chem. Commun., 2001, 381–382